Clinical Development & Late Stage Research

Pharma M&A
UBC - May 16, 2016
Patent expirations and mounting pricing pressures have fuelled record M&A activity throughout the pharma and biotech industry. This trend shows no sign of slowing down. In fact, PwC’s Health Research Institute predicts 2016 will...
UBC is raising awareness of clinical trials
Klaira McIntire, Associate Director, New Solutions - May 04, 2016
There is a misconception among patients that clinical trials are a “last-ditch effort,” and should be considered only after failing to respond to approved, conventional treatments.  And, even though there are currently 214,362...
Tagged in:
UBC - April 12, 2016
Project Managers are integral to everything we do here at UBC. They’re at the center of our clients’ programs, keeping a watchful eye on every detail, building strong relationships with stakeholders and ensuring deliverables are...
ICD0-10 codes in observational research
UBC - April 06, 2016
U.S. healthcare providers are now required to use the ICD-10 version of the World Health Organization’s classification of diseases.  The introduction of these disease and procedure codes creates significant analytic challenges...
Shazia Ahmad, Director, Patient & Physician Services - March 17, 2016
I had the opportunity to participate in Rare Disease Day 2016 while attending the National Institutes of Health (NIH) earlier this month in Bethesda, Maryland. I heard talks and saw presentations from the NIH Director, medical...

Pages